from Dreamers to Disruptors

NEXT New York is our flagship event, bringing together the world’s leading life sciences companies and thinkers to envision a transformative future for healthcare that challenges our preconceptions of what’s possible in clinical trials.This special edition of from Dreamers to Disruptors was recorded live from the show floor at NEXT, capturing the hottest takes and insights from Medidata leaders and special guests. From the end-to-end AI support reshaping studies, to building trust in cutting-edge clinical technologies, our speakers share their fresh perspectives on what matters most to pharma professionals today.Session 1 Speakers:Edward Ford | Vice President, Client Engagement, MedidataAnthony Costello | CEO, MedidataMatteo di Tommaso | Senior Vice President, R&D Business Insights & Technology, Bristol Myers SquibbNimita Limaye | Research Vice President, Life Sciences R&D Strategy and Technology, IDCSession 2 Speakers:Aryana Hosseinkhani | Vice President, Head of Product Marketing, MedidataMeghan Harrington | Vice President, Clinical Trial Financial Management, MedidataPaul O'Donohoe | Senior Director, eCOA Product and Science, MedidataSharlene Carnegie | Senior Vice President, Product and Engineering, MedidataSession 3 Speakers:Jeff Ventimiglia | Senior Vice President, Offering and Portfolio Management, MedidataBryant Fields | Vice President, Partnerships, MedidataRobert Lyons | Vice President, Engineering, MedidataJia Chen | Head, Product, AI, MedidataSession 4 Speakers: Lisa Moneymaker | Senior Vice President, Chief Strategy Officer, MedidataTom Doyle | Senior Vice President, Chief Technology Officer, MedidataClaire Biot | Vice President, Life Sciences and Healthcare Industry, Dassault SystèmesPatrick Johnson | EVP, Corporate Research and Sciences, Dassault SystèmesVisit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTube

As we enter the new year, the mandate is clear: evolve clinical research or get left behind.Join us to revisit conversations between Medidata CEO Anthony Costello and some of the leading industry minds—including Every Cure’s David Fajgenbaum, Digital Medicine Society’s Jennifer Goldsack, and Click Therapeutics’ David Klein—as they look to the future of life sciences in 2026 and beyond.From unlocking deeper data insights to scaling radical innovation, our guests issue a direct call to action: harness today’s cutting-edge technology to build a faster, smarter, and healthier world for patients everywhere.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedIn

Jennifer Goldsack has made it her mission to push the boundaries of how technology can enhance healthcare. As founder and CEO of the Digital Medicine Society (DiMe), she supports digital innovators exploring new ways to deliver better outcomes for patients everywhere.Jennifer and Medidata CEO Anthony Costello explore how clinical trials once led the way in life sciences digitization, why they’re falling behind, and how we can get our industry back on track.Join them to discover how Jennifer is promoting innovation and making smarter use of clinical data, as well as her personal story of navigating the healthcare system and confronting the everyday challenges patients face.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Jennifer: LinkedIn

Digital therapeutics are poised to transform healthcare as we know it, delivering Software-Enhanced Drugs™ to patients that extend and expand on traditional treatments, as well as valuable data and new commercial opportunities to pharmaceutical companies.Click Therapeutics is a leading light in prescription digital therapeutics, and CEO David Benshoof Klein’s insights into their design and implementation are second to none. He joins Medidata Solutions’ CEO Anthony Costello to explore the growth of evidence-based, Software-Enhanced Drugs™ and the art of creating effective technologies that change lives.Join David and Anthony to explore the vast potential of digital therapeutics for treating everything from migraines to cancer, and how to build solutions that genuinely benefit patients. They discuss the new Regulatory Considerations for Prescription Drug Use-Related Software (PDURS), and what new legislation means for the growth of software-based treatment adoption around the world.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow David: LinkedIn

Marisa Co has built a career based on intimate knowledge of every aspect of the pharmaceutical industry, giving her unparalleled insight into clinical trials and how to drive change in life sciences. Alongside senior roles at some of the biggest names in healthcare, her participation in the launch of Mytrus paved the way for decentralized clinical trials (DCTs).Join Marisa and Medidata CEO Anthony Costello as they dive into the technologies that enable DCTs to give patients ownership of their clinical trial journeys, and the AI boom that is transforming every aspect of clinical research.Marisa shares her unique insights into overcoming risk aversion within the clinical trials industry, and ensuring the successful adoption of game-changing technologies. She and Anthony dig into the progress of incorporating AI and eConsent into studies, and how to successfully deliver transformative change in healthcare.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Marisa: LinkedIn

As Bayer’s first Chief Digital Officer, Jessica Federer is a true pioneer in life sciences. An early driver of digital transformation in clinical research and a champion for women’s health, she has a unique grasp on the challenges we face, and the opportunities waiting to be realized.Listen as Medidata CEO Anthony Costello sits down with Jessica to explore her exceptional career, from her work to uplift women’s voices in the industry and tackle gender-based inequalities in healthcare, to the potential of AI, digital therapeutics, and other emerging technologies.Jessica shares her insights into the shocking underrepresentation of women in clinical trials, and why their inclusion is essential for our understanding of conditions including autoimmune diseases and Alzheimer’s. She and Anthony explore roadblocks to digital adoption in clinical trials, and how pharma companies can promote innovative treatments like precision medicine to transform patient experiences and outcomes.Visit our website: www.medidata.comRead our blog: Clinical MindsFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Jessica: LinkedIn, Instagram, X, Bluesky